Jakub Hlávka is an adjunct policy researcher at the RAND Corporation. His research addresses public and private sector R&D investment; the impacts of innovation in health care; and the theory and practice of national security. At RAND he has contributed to studies for NASA, the Office of the Secretary of Defense, the Department of Health and Human Services, and other national and international clients.
He currently serves as a research assistant professor of health policy and management at the USC Price School of Public Policy where he conducts research in health economics related to Alzheimer's disease, health technology assessment, and innovative payment models for high-cost medications.
Prior to joining RAND, Hlávka served in research and consulting roles at the Fraunhofer Society in Germany, at RAND Europe in the UK and Belgium, and at the Czech Government and the Ministry of Finance in Prague. He has worked on intellectual property regulation, defense and aerospace industry trade, 3D printing, fight against corruption and the regulation of capital markets.
He has also worked with the Hoover Institution at Stanford University and the Prague Security Studies Institute as a regulatory and security policy scholar. He is fluent in Czech, English, German, and French. Hlávka received a Ph.D. from the Pardee RAND Graduate School and also holds other degrees from Georgetown University and the University of Economics in Prague.
Selected Publications
JP Hlávka, PJ Lin, PJ Neumann, "Outcome measures for oncology alternative payment models: practical considerations and recommendations," The American Journal of Managed Care, 25(12), 2019
Jenny Lam, Jakub Hlávka, Soeren Mattke, "The Potential Emergence of Disease-Modifying Treatments for Alzheimer Disease: The Role of Primary Care in Managing the Patient Journey," The Journal of the American Board of Family Medicine, 32(6), 2019
Jakub P. Hlavka, Soeren Mattke, Jodi L. Liu, Assessing the Preparedness of the Health Care System Infrastructure in Six European Countries for an Alzheimer's Treatment, RAND Corporation (RR-2503), 2018
Andrew W. Mulcahy, Jakub P. Hlavka, Spencer R. Case, Biosimilar Cost Savings in the United States, RAND Corporation (PE-264), 2017
Christopher Paul, Colin P. Clarke, Michael Schwille, Jakub P. Hlavka, Michael A. Brown, Steven S. Davenport, Isaac R. Porche III, Joel Harding, Lessons from Others for Future U.S. Army Operations in and Through the Information Environment, RAND Corporation (RR-1925.1), 2018
